Technical Analysis for NEPT - Neptune Technologies & Bioresources Inc

Grade Last Price % Change Price Change
grade F 3.8 -5.94% -0.24
NEPT closed down 5.94 percent on Thursday, September 19, 2019, on approximately normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical NEPT trend table...

Date Alert Name Type % Chg
Fell Below 200 DMA Bearish 0.00%
MACD Bearish Signal Line Cross Bearish 0.00%
Stochastic Reached Oversold Weakness 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Down 3 Days in a Row Weakness -5.94%

Older signals for NEPT ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Neptune Technologies & Bioressources Inc., a biotechnology company, focuses on the research, development, and commercialization of products derived from marine biomasses for the nutraceutical and pharmaceutical industries. It produces marine-derived omega-3 polyunsaturated fatty acids, including Neptune Krill Oil (NKO), a dietary supplement for heart, joint, women, and brain health; ECOKRILL Oil (EKO), a krill product; and Neptune Krill Aquatein (NKA), a protein ingredient used in the production of nursing feed for young animals. The company also develops active pharmaceutical ingredients for cardiovascular and neurological diseases; and prescription drugs and medical foods for the safe and effective management of cognitive, behavioral, and neurodegenerative disorders. Neptune Technologies & Bioressources sells its products in Canada, the United States, France, Belgium, Australia, Japan, and other countries. The company was founded in 1925 and is headquartered in Laval, Canada.
Biotechnology Health Nutrition Active Pharmaceutical Ingredients Dietary Supplements Dietary Supplement Lipids Neurodegenerative Disorders Nutraceutical Fatty Acids Omega 3 Fatty Acid Saturated Fat
Is NEPT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.57
52 Week Low 2.421
Average Volume 1,260,006
200-Day Moving Average 3.9464
50-Day Moving Average 4.805
20-Day Moving Average 4.191
10-Day Moving Average 4.259
Average True Range 0.2576
ADX 24.77
+DI 16.717
-DI 29.8689
Chandelier Exit (Long, 3 ATRs ) 3.8872
Chandelier Exit (Short, 3 ATRs ) 4.5328
Upper Bollinger Band 4.5761
Lower Bollinger Band 3.8059
Percent B (%b) -0.01
BandWidth 18.377476
MACD Line -0.1544
MACD Signal Line -0.1488
MACD Histogram -0.0056
Fundamentals Value
Market Cap 298.85 Million
Num Shares 78.6 Million
EPS 0.07
Price-to-Earnings (P/E) Ratio 54.29
Price-to-Sales 1.90
Price-to-Book 1.27
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.25
Resistance 3 (R3) 4.29 4.17 4.18
Resistance 2 (R2) 4.17 4.06 4.16 4.15
Resistance 1 (R1) 3.99 3.99 3.93 3.95 4.12
Pivot Point 3.87 3.87 3.85 3.86 3.87
Support 1 (S1) 3.69 3.76 3.63 3.65 3.48
Support 2 (S2) 3.57 3.69 3.56 3.45
Support 3 (S3) 3.39 3.57 3.43
Support 4 (S4) 3.35